Beck Mack & Oliver’s Lumexa Imaging Holdings LMRI Stock Holding History

Beck Mack & Oliver’s Portfolio LMRI Stock Details LMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	+170,700	New	+$1.56M	0.04%	97

Other funds holding LMRI

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Think Investments San Francisco, California $847M AUM 88.1% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Beck Mack & Oliver's LMRI Position: Q2 2026 in Review

Beck Mack & Oliver opened a new position in Lumexa Imaging Holdings (LMRI) in Q2 2026: 170,700 shares worth $1.93M. The stake represents 0.04% of the portfolio and ranks #97 among its holdings.

103 funds tracked by Wall St. Rank hold LMRI as of Q2 2026.

Beck Mack & Oliver held 170,700 shares of Lumexa Imaging Holdings worth $1.93M as of Q2 2026.
Lumexa Imaging Holdings was a new Beck Mack & Oliver position in Q2 2026.
Lumexa Imaging Holdings made up 0.04% of Beck Mack & Oliver's portfolio in Q2 2026, its #97 holding.
103 funds tracked by Wall St. Rank held Lumexa Imaging Holdings as of Q2 2026.

Based on Beck Mack & Oliver's 13F filing for Q2 2026, filed 14 Aug 2026.